Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mature Local Control and Reirradiation Rates Comparing Spine Stereotactic Body Radiation Therapy With Conventional Palliative External Beam Radiation Therapy.
Zeng KL, Myrehaug S, Soliman H, Husain ZA, Tseng CL, Detsky J, Ruschin M, Atenafu EG, Witiw CD, Larouche J, da Costa L, Maralani PJ, Parulekar WR, Sahgal A. Zeng KL, et al. Among authors: larouche j. Int J Radiat Oncol Biol Phys. 2022 Oct 1;114(2):293-300. doi: 10.1016/j.ijrobp.2022.05.043. Epub 2022 Jun 5. Int J Radiat Oncol Biol Phys. 2022. PMID: 35675854 Free article. Clinical Trial.
Proposing a quantitative MRI-based linear measurement framework for response assessment following stereotactic body radiation therapy in patients with spinal metastasis.
Jabehdar Maralani P, Chen H, Moazen B, Mojtahed Zadeh M, Salehi F, Chan A, Zeng LK, Abugharib A, Tseng CL, Husain Z, Myrehaug S, Soliman H, Detsky J, Heyn C, Ruschin M, Larouche J, Sahgal A. Jabehdar Maralani P, et al. Among authors: larouche j. J Neurooncol. 2022 Oct;160(1):265-272. doi: 10.1007/s11060-022-04152-y. Epub 2022 Oct 7. J Neurooncol. 2022. PMID: 36203028
Dose-Escalated 2-Fraction Spine Stereotactic Body Radiation Therapy: 28 Gy Versus 24 Gy in 2 Daily Fractions.
Zeng KL, Abugarib A, Soliman H, Myrehaug S, Husain ZA, Detsky J, Ruschin M, Karotki A, Atenafu EG, Larouche J, Campbell M, Maralani P, Sahgal A, Tseng CL. Zeng KL, et al. Among authors: larouche j. Int J Radiat Oncol Biol Phys. 2023 Mar 1;115(3):686-695. doi: 10.1016/j.ijrobp.2022.09.076. Epub 2022 Oct 26. Int J Radiat Oncol Biol Phys. 2023. PMID: 36309076 Clinical Trial.
30 Gy in 4 Stereotactic Body Radiotherapy Fractions for Complex Spinal Metastases: Mature Outcomes Supporting This Novel Regimen.
Moore-Palhares D, Sahgal A, Zeng KL, Myrehaug S, Tseng CL, Detsky J, Chen H, Ruschin M, Atenafu EG, Wilson J, Larouche J, da Costa L, Maralani PJ, Soliman H. Moore-Palhares D, et al. Among authors: larouche j. Neurosurgery. 2023 Oct 1;93(4):813-823. doi: 10.1227/neu.0000000000002498. Epub 2023 Apr 19. Neurosurgery. 2023. PMID: 37074052
Quality of life issues in patients with bone metastases: A systematic review.
Rajeswaran T, Wong HCY, Zhang E, Kennedy SKF, Gojsevic M, Soliman H, Vassiliou V, Rades D, Bonomo P, Lee SF, Chan AW, Rembielak A, Oldenburger E, Maranzano E, Pergolizzi S, Finkelstein JA, Larouche J, Zhang N, Zhang X, Marta GN, Yee AJM, Yu S, van der Velden JM, van der Linden YM, Chow E; EORTC Quality of Life Group. Rajeswaran T, et al. Among authors: larouche j. Support Care Cancer. 2023 Dec 13;32(1):18. doi: 10.1007/s00520-023-08241-0. Support Care Cancer. 2023. PMID: 38091116 Review.
Stereotactic Body Radiation Therapy for Sacral Metastases: Deviation From Recommended Target Volume Delineation Increases the Risk of Local Failure.
Moore-Palhares D, Zeng KL, Tseng CL, Chen H, Myrehaug S, Soliman H, Maralani P, Larouche J, Shakil H, Jerzak K, Ruschin M, Zhang B, Atenafu EG, Sahgal A, Detsky J. Moore-Palhares D, et al. Among authors: larouche j. Int J Radiat Oncol Biol Phys. 2024 Feb 22:S0360-3016(24)00282-7. doi: 10.1016/j.ijrobp.2024.01.213. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 38395085 Free article.
Utility of molecular markers in predicting local control specific to lung cancer spine metastases treated with stereotactic body radiotherapy.
Shor D, Louie AV, Zeng KL, Menjak IB, Atenafu EG, Chia-Lin Tseng, Detsky J, Larouche J, Zhang B, Soliman H, Myrehaug S, Maralani P, Hwang DM, Sahgal A, Chen H. Shor D, et al. Among authors: larouche j. J Neurooncol. 2024 Apr;167(2):275-283. doi: 10.1007/s11060-024-04603-8. Epub 2024 Mar 25. J Neurooncol. 2024. PMID: 38526757
95 results